Alopecia areata during treatment with biologic agents [5]

Archives of Dermatology

Volumn 142, Issue 12, 2006, Pages 1653-1654

  Tosti, Antonella ^a   Pazzaglia, Massimiliano ^b   Starace, Michela ^b   Bellavista, Sara ^b   Vincenzi, Colombina ^b   Tonelli, Gabriella ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALEFACEPT; CLOBETASOL PROPIONATE; EFALIZUMAB; ETANERCEPT; INFLIXIMAB;

ADULT; ALOPECIA AREATA; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG WITHDRAWAL; HUMAN; LETTER; MALE; PRIORITY JOURNAL; PSORIATIC ARTHRITIS; PUSTULAR PSORIASIS;

ADULT; ALOPECIA AREATA; ANTIBODIES, MONOCLONAL; CELL MIGRATION INHIBITION; DERMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845703763     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.142.12.1653     Document Type: Letter

References (5)

1. Price VH. Therapy of alopecia areata: on the cusp and in the future. J Investig Dermatol Symp Proc. 2003;8:207-211.
2. Ettefagh L, Nedorost S, Mirmirani P. Alopecia areata in a patient using infliximab: new insight into the role of tumor necrosis factor on human hair follicle. Arch Dermatol. 2004;140:1012.
3. Posten W, Swan J. Recurrence of alopecia areata in a patient receiving etanercept injections. Arch Dermatol. 2005;141:759-760.
4. Misciali C, Peluso AM, Cameli N, Tosti A. Occurrence of alopecia areata in a patient receiving systemic cyclosporine A. Arch Dermatol. 1996;132:843-844.
5. Gupta AK, Ellis C, Cooper K. Oral cyclosporine for the treatment of alopecia areata: a clinical and immunohistochemical analysis. J Am Acad Dermatol. 1990;22:242-250.